# INTERMEDIATE-SIZE PATIENT POPULATIONS EXPANDED ACCESS TO TREATMENT FOR SARCOPENIC OBESITY

> **NCT06784297** · — · TEMPORARILY_NOT_AVAILABLE · sponsor: **Immunis, Inc.**

## Conditions studied

- Sarcopenia
- Obesity and Obesity-related Medical Conditions

## Interventions

- **BIOLOGICAL:** IMM01-STEM

## Key facts

- **NCT ID:** NCT06784297
- **Lead sponsor:** Immunis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** TEMPORARILY_NOT_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06784297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06784297, "INTERMEDIATE-SIZE PATIENT POPULATIONS EXPANDED ACCESS TO TREATMENT FOR SARCOPENIC OBESITY". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06784297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*